Literature DB >> 12587456

[Partial resection of the spleen and spleno-renal shunt in the treatment of portal hypertension with splenomegaly and hypersplenism].

B Radević1, R Jesić, D Sagić, V Perisić, D Nenezić, P Popov, N Ilijevski, V Dugalić, P Gajin, G Vucurević, Dj Radak, Z Trebjesanin, D Babić, D Kastratović, P Matić.   

Abstract

Some of serious hepatic diseases with cirrhosis may be complicated by portal hypertension, splenomegaly and hypersplenism. Splenomegaly inhibits regenerative processes of the liver, and also intensifies sequestration of the cellular components of blood up to hypersplenism. Cytopenia caused by hypersplenism is aggravated by negative hepatic influence on bone marrow activity-hemathopoesis, and also by recurrent bleeding from oesophageal varices, and from the other site of gastrointestinal tract. This circle of pathologic conditions may be interrupted only by liver transplantation, until which patients are jeopardized by acute bleeding and chronic anemia. Partial resection of the spleen and splenorenal shunt may correct portal hypertension and hypersplenism, prevent gastrointestinal bleeding, and alleviate hepatic regenerative processes inhibition. In this study, 51 patients with partial resection of the spleen and splenorenal shunt, were analyzed.

Entities:  

Mesh:

Year:  2002        PMID: 12587456     DOI: 10.2298/aci0203093r

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  2 in total

1.  Warren shunt combined with partial splenectomy for children with extrahepatic portal hypertension, massive splenomegaly, and severe hypersplenism.

Authors:  Aleksandar Lj Sretenovic; Vojislav Perišić; Zoran Krstić; Dragana Vujović; Polina Pavićević; Dejana Stanisavljević; Božina Radević
Journal:  Surg Today       Date:  2012-11-07       Impact factor: 2.549

2.  Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism.

Authors:  Wen-Tao Jiang; Jian Yang; Yan Xie; Qing-Jun Guo; Da-Zhi Tian; Jun-Jie Li; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2021-02-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.